MPX Archives

Debra BorchardtMarch 25, 2019

iAnthus Capital Holdings, Inc. (CSE: IAN) (OTCQX: ITHUF) is redeeming its outstanding convertible debentures of MPX Luxembourg SARL, a wholly-owned subsidiary of iAnthus, in the aggregate principal amount of $32,257,804.07. The redemption date of the Debentures will be April 24, 2019. The Debentures are redeemable for an amount equal to $860.43 per $1,000 principal amount […]

William SumnerNovember 30, 2018

MPX Bioceutical Corporation MPX Bioceutical Corporation (CSE: MPX) reported its financial results for the second quarter ended on September 30, 2018. MPX recorded revenue of CAD$14.7 million, up from CAD$4.4 million in the same quarter during the previous year. The increase in revenue was attributed to wholesale operations and the company’s management of four cannabis […]

William SumnerAugust 15, 2018

Constellation Brands (STZ), best known as the distributor for Corona beer, is doubling down on its investment in Canopy Growth Corporation (WEED) in what some are calling one the largest investments in cannabis history. On August 15, 2018, Constellation announced that it would acquire 104.5 million shares of Canopy, increasing its stake in the company […]

StaffMarch 5, 2018

Ontario-based MPX Bioceutical Corporation (MPXEF) announced that it has entered into an agreement valued at $15 million to acquire 100% of the membership units of ABACA, LLC, Ambary, LLC, Tarmac Manufacturing, LLC and Tower Management Holdings, LLC. ABACA is a fully-integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act, A.R.S. Title 36, […]

Debra BorchardtMarch 1, 2018

MPX Bioceutical Corp. (MPXEF) reported its third-quarter earnings with the caveat that comparing results to the previous year (2016) didn’t make sense since most of the assets were acquired in 2017. Instead, the earnings are being compared to the fiscal second quarter of 2018. Dispensary cannabis sales for the quarter ending December 31, 2017, were […]

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

In other news

The Daily Hit: January 4, 2024

Connecticut Attorney General Tells Unlicensed Cannabis Events Company to Stop

Testing Concerns Lead to Quarantine for 70% of Mississippi MMJ Goods

Tag: MPX

iAnthus, MPX Bioceuticals Make Money Moves

Earnings Roundup: , MPX Bioceutical, Plus Products, Emerald Health Therapeutics

Cannabis Industry Insiders React to Constellation’s Billion Dollar Canopy Investment

MPX Acquires The Holistic Center In Phoenix As U.S. Expansion Continues

MPX Bioceutical Revenues Increase In Third Quarter

The Daily Hit - TEST TEST TEST

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

Get the latest cannabis news delivered right to your inbox

Get the latest cannabis news delivered right to your inbox